| Issue Date | Title | Author(s) |
| 2013-01-01 | Cost-effectiveness of 12-month treatment with ticagrelor compared with clopidogrel in the management of acute coronary syndromes | Liew, D; De Abreu Lourenço, R; Adena, M; Chim, L; Aylward, P |
| 2016 | Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer. | Bloem, LT; De Abreu Lourenço, R; Chin, M; Ly, B; Haas, M |
| 2021-01-01 | Giving a Voice to Marginalised Groups for Health Care Decision Making. | De Abreu Lourenço, R; Devlin, N; Howard, K; Ong, JJ; Ratcliffe, J; Watson, J; Willing, E; Huynh, E |
| 2022-01 | GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol) | Conduit, C; Mak, B; Qu, W; Di Lulio, J; Burder, R; Bressel, M; Cusick, T; Dhillon, HM; De Abreu Lourenço, R; Underhill, C; Torres, J; Crumbaker, M; Honeyball, F; Linton, A; Allen, R; Davis, ID; Clark, SJ |
| 2019-07-01 | My mind is made up: Cancer concern and women’s preferences for contralateral prophylactic mastectomy | De Abreu Lourenço, R; Haas, M; Hall, J; Parish, K; Stuart, D; Viney, R |
| 2023-02-20 | PRIMARY2: A phase III, multi-centre, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancer. | Buteau, JP; Moon, D; Fahey, MT; Roberts, M; Thompson, J; Murphy, DG; Papa, N; Mitchell, C; Kasivisvanathan, V; Stricker, P; O'Brien, J; Counter, W; Sharma, G; Agrawal, S; Ho, B; Yeung, T; De Abreu Lourenço, R |
| 2023-08 | The Colorectal cancer RISk Prediction (CRISP) trial: a randomised controlled trial of a decision support tool for risk-stratified colorectal cancer screening. | Emery, JD; Jenkins, MA; Saya, S; Chondros, P; Oberoi, J; Milton, S; Novy, K; Habgood, E; Karnchanachari, N; Pirotta, M; Trevena, L; Bickerstaffe, A; De Abreu Lourenço, R; Crothers, A; Ouakrim, DA; Flander, L; Dowty, JG; Walter, FM; Clark, M; Doncovio, S; Etemadmoghadam, D; Fishman, G; Macrae, F; Winship, I; McIntosh, JG |
| 2023-02-20 | Trial in progress: PRESTIGE—Primary retroperitoneal lymph node dissection (RPLND) for clinical stage II (CSII) testicular germ cell tumour (TGCT) and its impact on health-related quality of life (HRQoL) compared to chemotherapy or radiotherapy. | Conduit, C; Lewin, JH; Liow, ECH; Dhillon, HM; Hong, W; De Abreu Lourenço, R; Lawrentschuk, N; Thomas, B; Grimison, PS; Ahmadi, N; Sengupta, S; Tran, B |
| 2018-07-25 | The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: Study protocol for a randomised controlled trial | Walker, JG; Macrae, F; Winship, I; Oberoi, J; Saya, S; Milton, S; Bickerstaffe, A; Dowty, JG; De Abreu Lourenço, R; Clark, M; Galloway, L; Fishman, G; Walter, FM; Flander, L; Chondros, P; Ait Ouakrim, D; Pirotta, M; Trevena, L; Jenkins, MA; Emery, JD |
